ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria boost: could a probiotic supercharge cancer treatment?
Disease control OngoingThis early-stage study is testing if adding a probiotic called CBM588 to standard cancer drugs (cabozantinib and nivolumab) can help patients with advanced kidney cancer. The probiotic aims to improve the mix of 'good' bacteria in the gut, which might help the body's immune syste…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Global race for better kidney cancer treatment
Disease control OngoingThis large global study is testing two new drug combinations for advanced kidney cancer that has spread. Researchers are comparing these new treatments against the current standard treatment to see which works better at controlling the cancer and helping patients live longer. The…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
New 'Seek-and-Destroy' radiation therapy tested for Tough-to-Treat kidney cancer
Disease control OngoingThis study is testing whether a targeted radiation drug called 177Lu-PSMA-617 can help control advanced kidney cancer that has spread. The treatment works by seeking out cancer cells and delivering radiation directly to them. The trial involves about 24 patients whose cancer has …
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
New hope for tough kidney cancers: Head-to-Head drug battle begins
Disease control OngoingThis study compares two different drug treatments for people with advanced kidney cancer that has spread and continued to grow despite previous immunotherapy. Researchers want to see whether a combination of two drugs (lenvatinib plus everolimus) works better than a single drug (…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC